Structural requirements of steroids for their action as inhibitors of oxidative phosphorylation. Effect of alpha-tocopherol on the inhibition of oxidative phosphorylation by progesterone.
D000818:Animals; D006885:Hydroxybutyrates / Q000378:metabolism; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010101:Oxygen Consumption / Q000187:drug effects; D011374:Progesterone / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D011956:Receptors, Cell Surface; D012402:Rotenone / Q000494:pharmacology; D013386:Succinates / Q000378:metabolism; D014810:Vitamin E / Q000494:pharmacology*
D006885:Hydroxybutyrates; D011956:Receptors, Cell Surface; D013386:Succinates; D012402:Rotenone; D009243:NAD; D014810:Vitamin E; D011374:Progesterone